Free Trial

Orchestra BioMed (OBIO) Institutional Ownership

Orchestra BioMed logo
$2.61 -0.10 (-3.69%)
Closing price 04:00 PM Eastern
Extended Trading
$2.56 -0.05 (-1.92%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)

Current
Institutional Ownership
Percentage
53.20%
Number of
Institutional Buyers
(last 12 months)
28
Total
Institutional Inflows
(last 12 months)
$16.92M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$1.41M
Get OBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OBIO Institutional Buying and Selling by Quarter

Orchestra BioMed Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025Tower Research Capital LLC TRC 27,922$75K0.0%+1,137.7%0.072%
8/15/2025Bridgeway Capital Management LLC25,000$67K0.0%N/A0.065%
8/15/2025Bank of America Corp DE21,577$58K0.0%+35.7%0.056%
8/14/2025Jane Street Group LLC18,513$50K0.0%N/A0.048%
8/14/2025The Manufacturers Life Insurance Company 32,518$87K0.0%-22.5%0.084%
8/14/2025NewEdge Advisors LLC44,083$118K0.0%N/A0.114%
8/13/2025Marshall Wace LLP49,465$133K0.0%N/A0.128%
8/12/2025XTX Topco Ltd16,817$45K0.0%N/A0.044%
8/12/2025Catalyst Funds Management Pty Ltd11,400$31K0.0%N/A0.030%
8/11/2025Knott David M Jr100,000$268K0.1%N/A0.259%
8/8/2025Creative Planning15,000$40K0.0%N/A0.039%
8/8/2025Geode Capital Management LLC302,082$810K0.0%-49.3%0.782%
8/1/2025Y Intercept Hong Kong Ltd45,447$122K0.0%N/A0.119%
7/24/2025IFP Advisors Inc85,358$229K0.0%-47.3%0.223%
6/27/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/16/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/13/2025HighTower Advisors LLC61,000$261K0.0%-10.9%0.159%
5/12/2025Nuveen LLC41,729$179K0.0%N/A0.109%
5/9/2025Deutsche Bank AG20,219$87K0.0%+67.3%0.053%
5/5/2025IFP Advisors Inc161,921$693K0.0%+106.4%0.423%
2/17/2025Millennium Management LLC21,513$86K0.0%N/A0.057%
2/17/2025Citadel Advisors LLC12,279$49K0.0%-39.0%0.032%
2/17/2025Bank of America Corp DE23,780$95K0.0%+42.0%0.063%
2/14/2025Boxer Capital Management LLC238,193$953K0.1%N/A0.627%
2/14/2025Northern Trust Corp236,761$947K0.0%+2.5%0.623%
2/14/2025The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097%
2/14/2025Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282%
2/13/2025Barclays PLC37,786$152K0.0%+18.9%0.099%
2/13/2025Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035%
2/12/2025Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506%
2/12/2025JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130%
2/7/2025HighTower Advisors LLC68,500$274K0.0%+34.3%0.180%
1/17/2025SG Americas Securities LLC12,785$51K0.0%+26.0%0.034%
11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%
11/19/2024Barclays PLC31,785$163K0.0%+281.3%0.084%
11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%
11/15/2024Barclays PLC31,785$163K0.0%+281.3%0.084%
11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050%
11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130%
11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%
11/13/2024The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088%
11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%
11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035%
10/3/2024SG Americas Securities LLC10,143$52K0.0%N/A0.028%
8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056%
8/15/2024The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118%
8/1/2024Rhumbline Advisers26,439$215K0.0%+192.7%0.074%
7/26/2024Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197%
5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%
5/11/2024Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062%
2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%
10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%
10/27/2023TD Asset Management Inc92,678$808K0.0%+100.0%0.259%
10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113%
10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009%
10/13/2023Arkadios Wealth Advisors51,595$450K0.0%N/A0.144%
8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%
8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181%
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%
5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652%
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%
(Data available from 1/1/2016 forward)

OBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OBIO shares?

During the previous two years, 40 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), Boxer Capital Management LLC ($953K), Northern Trust Corp ($947K), and Geode Capital Management LLC ($810K).Learn more on Orchestra BioMed's institutional investors.

What percentage of Orchestra BioMed's stock is owned by institutional investors?

53.20% of Orchestra BioMed's stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings.

Which institutional investors have been buying Orchestra BioMed's stock?

Of the 36 institutional investors that purchased Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), Knott David M Jr ($100K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K).

How much institutional buying is happening at Orchestra BioMed?

Institutional investors have bought a total of 3,562,853 shares in the last 24 months. This purchase volume represents approximately $16.92M in transactions.

Which of Orchestra BioMed's major shareholders have been selling company stock?

Of the 9 institutional investors that sold Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($293.35K), IFP Advisors Inc ($76.56K), Goldman Sachs Group Inc. ($26.82K), Price T Rowe Associates Inc. MD ($25.49K), The Manufacturers Life Insurance Company ($18.24K), Citadel Advisors LLC ($7.84K), and SkyView Investment Advisors LLC ($7.72K).

How much institutional selling is happening at Orchestra BioMed?

Institutional investors have sold a total of 468,229 shares in the last 24 months. This volume of shares sold represents approximately $1.41M in transactions.



This page (NASDAQ:OBIO) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners